We are BioNexus Status company dedicated to research, development, manufacturing and commercialization of microbial-based bio-therapeutic products for human consumption and to undertake its related research and development activities and clinical trials.,Our Mission,B-Crobes is steadfast in its commitment to enhance the healthcare landscape in Malaysia through the provision of scientifically supported products. We are deeply engaged in the research and development of probiotics, employing biotechnology since our inception. Our relentless efforts have been directed towards substantiating the inherent value and benefits of probiotics. The MCP® BCMC® strains, our proprietary house-strains, represent a culmination of over 20 clinical studies, and our dedication to advancing knowledge in this domain remains unwavering.,Our Vision,To be a global leader in advancing healthcare through innovative, science-backed products benefitting the people. B-Crobes envisions a future where our reach extends to every corner of the globe, contributing to the well-being of diverse communities. As we continue to export to 15 countries worldwide, our aspiration is to be recognized as the foremost choice in healthcare solutions. In addition, we envision B-Crobes products becoming an indispensable adjunctive treatment in hospitals globally, symbolizing our commitment to excellence in healthcare on a global scale.